Ya-Hui Li1, Xiao-Jun Huang1, Xiang-Yu Zhao1

  • 1Peking University People's Hospital, Peking University Institute of Haematology, National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China.

Cancer letters
|February 9, 2025
PubMed
概括

免疫突触对于像T细胞这样的免疫细胞来攻击瘤并产生抗体至关重要. 增强它们的功能是促进免疫反应和开发新疗法的关键.